Insulin-like growth factor II receptor-mediated intracellular retention of cathepsin B is essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus

Journal of Virology

Volumn 81, Issue 15, 2007, Pages 8050-8062

  Rose, Patrick P ^a   Bogyo, Matthew ^b   Moses, Ashlee V ^a   Früh, Klaus ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; SMALL INTERFERING RNA; SOMATOMEDIN B RECEPTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOSOME; ENDOTHELIUM CELL; HUMAN HERPESVIRUS 8; IN VITRO STUDY; INSULIN LIKE ACTIVITY; KAPOSI SARCOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; SPINDLE CELL; VASCULAR ENDOTHELIUM; VIRUS INHIBITION; VIRUS TRANSFORMATION;

ANTIGENS, VIRAL; APOPTOSIS; CATHEPSIN B; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CONTACT INHIBITION; DIPEPTIDES; ENDOTHELIAL CELLS; ENZYME PRECURSORS; HERPESVIRUS 8, HUMAN; HUMANS; NUCLEAR PROTEINS; RECEPTOR, IGF TYPE 2; RNA, SMALL INTERFERING; SARCOMA, KAPOSI;

HUMAN HERPESVIRUS 8;

EID: 34547111780     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00249-07     Document Type: Article

References (58)

1. Baici, A., K. Muntener, A. Willimann, and R. Zwicky. 2006. Regulation of human cathepsin B by alternative mRNA splicing: homeostasis, fatal errors and cell death. Biol. Chem. 387:1017-1021.
2. Berquin, I. M., L. Cao, D. Fong, and B. F. Sloane. 1995. Identification of two new exons and multiple transcription start points in the 5′-untranslated region of the human cathepsin-B-encoding gene. Gene 159:143-149.
3. Berthe, M. L., M. Esslimani Sahla, P. Roger, M. Gleizes, G. J. Lemamy, J. P. Brouillet, and H. Rochefort. 2003. Mannose-6-phosphate/insulin-like growth factor-II receptor expression levels during the progression from normal human mammary tissue to invasive breast carcinomas. Eur. J. Cancer 39:635-642.
4. Boshoff, C., and Y. Chang. 2001. Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus. Annu. Rev. Med. 52:453-470.
5. Bursch, W. 2001. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. 8:569-581.
6. Chapman, H. A., R. J. Riese, and G. P. Shi. 1997. Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59:63-88.
7. Cianfrocca, M., T. P. Cooley, J. Y. Lee, M. A. Rudek, D. T. Scadden, L. Ratner, J. M. Pluda, W. D. Figg, S. E. Krown, and B. J. Dezube. 2002. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J. Clin. Oncol. 20:153-159.
8. Dourmishev, L. A., A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac. 2003. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol. Mol. Biol. Rev. 67:175-212.
9. Felbor, U., L. Dreier, R. A. Bryant, H. L. Ploegh, B. R. Olsen, and W. Mothes. 2000. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J. 19:1187-1194.
10. Frlan, R., and S. Gobec. 2006. Inhibitors of cathepsin B. Curr. Med. Chem. 13:2309-2327.
11. Guasparri, I., S. A. Keller, and E. Cesarman. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199:993-1003.
12. Guicciardi, M. E., J. Deussing, H. Miyoshi, S. F. Bronk, P. A. Svingen, C. Peters, S. H. Kaufmann, and G. J. Gores. 2000. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Investig. 106:1127-1137.
13. Hawkes, C., and S. Kar. 2004. The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system. Brain Res. Brain Res. Rev. 44:117-140.
14. Hébert, E. 2006. Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development. Biosci. Rep. 26:7-17.
15. Hengge, U. R., T. Ruzicka, S. K. Tyring, M. Stuschke, M. Roggendorf, R. A. Schwartz, and S. Seeber. 2002. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect. Dis. 2:281-292.
16. Hill, P. A., D. J. Buttle, S. J. Jones, A. Boyde, M. Murata, J. J. Reynolds, and M. C. Meikle. 1994. Inhibition of bone resorption by selective inactivators of cysteine proteinases. J. Cell. Biochem. 56:118-130.
17. Huang, Q., A. Raya, P. DeJesus, S. H. Chao, K. C. Quon, J. S. Caldwell, S. K. Chanda, J. C. Izpisua-Belmonte, and P. G. Schultz. 2004. Identification of p53 regulators by genome-wide functional analysis. Proc. Natl. Acad. Sci. USA 101:3456-3461.
18. Huet, G., R. M. Flipo, C. Colin, A. Janin, B. Hemon, M. Collyn-d'Hooghe, R. Lafyatis, B. Duquesnoy, and P. Degand. 1993. Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor alpha and interleukin-1. Arthritis Rheum. 36:772-780.
19. Im, E., A. Venkatakrishnan, and A. Kazlauskas. 2005. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol. Biol. Cell 16:3488-3500.
20. Jenner, R. G., and C. Boshoff. 2002. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim. Biophys. Acta 1602:1-22.
21. Joyce, J. A., A. Baruch, K. Chehade, N. Meyer-Morse, E. Giraudo, F. Y. Tsai, D. C. Greenbaum, J. H. Hager, M. Bogyo, and D. Hanahan. 2004. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5:443-453.
22. Joyce, J. A., and D. Hanahan. 2004. Multiple roles for cysteine cathepsins in cancer. Cell Cycle 3:1516-1519.
23. Krueger, S., C. Haeckel, F. Buehling, and A. Roessner. 1999. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line. Cancer Res. 59:6010-6014.
24. Lakka, S. S., C. S. Gondi, and J. S. Rao. 2005. Proteases and glioma angiogenesis. Brain Pathol. 15:327-341.
25. Lakka, S. S., C. S. Gondi, N. Yanamandra, W. C. Olivero, D. H. Dinh, M. Gujrati, and J. S. Rao. 2004. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 23:4681-4689.
26. Leist, M., and M. Jaattela. 2001. Triggering of apoptosis by cathepsins. Cell Death Differ. 8:324-326.
27. Li, J. H., and J. S. Pober. 2005. The cathepsin B death pathway contributes to TNF plus IFN-γ-mediated human endothelial injury. J. Immunol. 175:1858-1866.
28. -ΔΔCT method. Methods 25:402-408.
29. Lorenzo, K., P. Ton, J. L. Clark, S. Coulibaly, and L. Mach. 2000. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor. Cancer Res. 60:4070-4076.
30. McAllister, S. C., S. G. Hansen, R. A. Ruhl, C. M. Raggo, V. R. DeFilippis, D. Greenspan, K. Fruh, and A. V. Moses. 2004. Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood 103:3465-3473.
31. McAllister, S. C., and A. V. Moses (ed.). 2007. Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology. Springer Verlag, Heidelberg, Germany.
32. Mehtani, S., Q. Gong, J. Panella, S. Subbiah, D. M. Peffley, and A. Frankfater. 1998. In vivo expression of an alternatively spliced human tumor message that encodes a truncated form of cathepsin B. Subcellular distribution of the truncated enzyme in COS cells. J. Biol. Chem. 273:13236-13244.
33. Mohanam, S., S. L. Jasti, S. R. Kondraganti, N. Chandrasekar, S. S. Lakka, Y. Kin, G. N. Fuller, A. W. Yung, A. P. Kyritsis, D. H. Dinh, W. C. Olivero, M. Gujrati, F. Ali-Osman, and J. S. Rao. 2001. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Oncogene 20:3665-3673.
34. Montaser, M., G. Lalmanach, and L. Mach. 2002. CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells. Biol. Chem. 383:1305-1308.
35. Moore, P. S., and Y. Chang. 2003. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin? Annu. Rev. Microbiol. 57:609-639.
36. Moschos, S. J., and C. S. Mantzoros. 2002. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63:317-332.
37. Moses, A. V., K. N. Fish, R. Ruhl, P. P. Smith, J. G. Strussenberg, L. Zhu, B. Chandran, and J. A. Nelson. 1999. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J. Virol. 73:6892-6902.
38. Moses, A. V., M. A. Jarvis, C. Raggo, Y. C. Bell, R. Ruhl, B. G. Luukkonen, D. J. Griffith, C. L. Wait, B. J. Druker, M. C. Heinrich, J. A. Nelson, and K. Fruh. 2002. A functional genomics approach to Kaposi's sarcoma. Ann. N. Y. Acad. Sci. 975:180-191.
39. Moses, A. V., M. A. Jarvis, C. Raggo, Y. C. Bell, R. Ruhl, B. G. Luukkonen, D. J. Griffith, C. L. Wait, B. J. Druker, M. C. Heinrich, J. A. Nelson, and K. Fruh. 2002. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. J. Virol. 76:8383-8399.
40. O'Gorman, D. B., J. Weiss, A. Hettiaratchi, S. M. Firth, and C. D. Scott. 2002. Insulin-like growth factor-II/mannose 6-phosphate receptor overexpression reduces growth of choriocarcinoma cells in vitro and in vivo. Endocrinology 143:4287-4294.
41. Palmer, J. T., D. Rasnick, J. L. Klaus, and D. Bromme. 1995. Vinyl sulfones as mechanism-based cysteine protease inhibitors. J. Med. Chem. 38:3193-3196.
42. Raggo, C., R. Ruhl, S. McAllister, H. Koon, B. J. Dezube, K. Fruh, and A. V. Moses. 2005. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res. 65:5084-5095.
43. Rose, P. P., J. M. Carroll, P. A. Carroll, V. R. Defilippis, M. Lagunoff, A. V. Moses, C. T. Roberts, Jr., and K. Früh. 2007. The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma. Oncogene 26:1995-2005.
44. Roshy, S., B. F. Sloane, and K. Moin. 2003. Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev. 22:271-286.
45. Scharf, J. G., and T. Braulke. 2003. The role of the IGF axis in hepatocarcinogenesis. Horm. Metab. Res. 35:685-693.
46. Schwartz, R. A., and W. C. Lambert. May 2006, posting date. Kaposi sarcoma. Emedicine from WebMD. http://www.emedicine.com/derm/topic203.htm.
47. Sloane, B., K. Moin, M. Sameni, L. Tait, J. Rozhin, and G. Ziegler. 1994. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J. Cell Sci. 107:373-384.
48. Sloane, B. F., S. Yan, I. Podgorski, B. E. Linebaugh, M. L. Cher, J. Mai, D. Cavallo-Medved, M. Sameni, J. Dosescu, and K. Moin. 2005. Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment. Semin. Cancer Biol. 15:149-157.
49. Szpaderska, A. M., and A. Frankfater. 2001. An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res. 61:3493-3500.
50. Thurmond, R. L., S. Sun, L. Karlsson, and J. P. Edwards. 2005. Cathepsin S inhibitors as novel immunomodulators. Curr. Opin. Investig. Drugs 6:473-482.
51. Turk, B., D. Turk, and V. Turk. 2000. Lysosomal cysteine proteases: more than scavengers. Biochim. Biophys. Acta 1477:98-111.
52. Turk, D., and G. Guncar. 2003. Lysosomal cysteine proteases (cathepsins): promising drug targets. Acta Crystallogr. D 59:203-213.
53. Turk, V., J. Kos, and B. Turk. 2004. Cysteine cathepsins (proteases) - on the main stage of cancer? Cancer Cell 5:409-410.
54. Turk, V., B. Turk, and D. Turk. 2001. Lysosomal cysteine proteases: facts and opportunities. EMBO J. 20:4629-4633.
55. Wang, H. W., M. W. Trotter, D. Lagos, D. Bourboulia, S. Henderson, T. Makinen, S. Elliman, A. M. Flanagan, K. Alitalo, and C. Boshoff. 2004. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet. 36:687-693.
56. Wang, Z. Q., M. R. Fung, D. P. Barlow, and E. F. Wagner. 1994. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372:464-467.
57. Yan, S., and B. F. Sloane. 2003. Molecular regulation of human cathepsin B: implication in pathologies. Biol. Chem. 384:845-854.
58. Yanamandra, N., K. V. Gumidyala, K. G. Waldron, M. Gujrati, W. C. Olivero, D. H. Dinh, J. S. Rao, and S. Mohanam. 2004. Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis. Oncogene 23:2224-2230.